Trials / Unknown
UnknownNCT04215393
An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization
An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of Conbercept Eye Drops in Patients With Corneal Neovascularization
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 39 (estimated)
- Sponsor
- Chengdu Kanghong Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The first stage of this study will evaluates the tolerability of different concentrations of Conbercept eye drop to patients with corneal neovascularization. The second stage of this study will evaluate the effectiveness of conbercept eye drop initially.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Conbercept eye drop | In the first stage, subjects will be receive Conbercept eye drop. In the second stage,subjests will revceive conbercept eye drop or placebo. |
| DRUG | Placebo | In the second stage, subjects will be receive Conbercept eys drop or a placebo. |
Timeline
- Start date
- 2019-07-18
- Primary completion
- 2020-04-01
- Completion
- 2020-12-01
- First posted
- 2020-01-02
- Last updated
- 2020-01-02
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04215393. Inclusion in this directory is not an endorsement.